Clinical trial
Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic…
NCT00287885 · Masonic Cancer Center, University of Minnesota, Other · Completed
Key facts
| NCT number | NCT00287885 |
|---|---|
| Title | Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer |
| Official title | Phase I Study of Metronomic Daily Dosing of Docetaxel in Women With Progressive or Recurrent Gynecologic Cancer |
| Lead sponsor | Masonic Cancer Center, University of Minnesota, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cervical Cancer, Endometrial Cancer, Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer, Sarcoma, Vaginal Cancer, Vulvar Cancer |
| Intervention type | Drug |
| Interventions | docetaxel |
| Enrollment | 18 |
| Start date | Mar 1, 2004 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Feb 7, 2006 |
| Last update posted | Nov 29, 2017 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: